Circulating tumor cells in breast cancer: A tool whose time has come of age

by Cristofanilli Massimo, Swaby Ramona F
Published 2011-04-01

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells

by Buchholz Thomas A, Lacerda Lara, Xu Wei, Robertson Fredika, Ueno Naoto T, Lucci Anthony, Landis Melissa D, Rodriguez Angel A, Li Li, Cohen Evan, Gao Hui, Krishnamurthy Savitri, Zhang Xiaomei, Debeb Bisrat G, Cristofanilli Massimo, Reuben James M, Lewis Michael T, Woodward Wendy A
Published 2010-07-01

Considerations in the development of circulating tumor cell technology for clinical use

by Parkinson David R, Dracopoli Nicholas, Petty Brenda, Compton Carolyn, Cristofanilli Massimo, Deisseroth Albert, Hayes Daniel F, Kapke Gordon, Kumar Prasanna, Lee Jerry SH, Liu Minetta C, McCormack Robert, Mikulski Stanislaw, Nagahara Larry, Pantel Klaus, Pearson-White Sonia, Punnoose Elizabeth A, Roadcap Lori T, Schade Andrew E, Scher Howard I, Sigman Caroline C, Kelloff Gary J
Published 2012-07-01

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

by Tefferi, Ayalew, Kantarjian, Hagop, Rajkumar, S Vincent, Baker, Lawrence H, Abkowitz, Jan L, Adamson, John W, Advani, Ranjana Hira, Allison, James, Antman, Karen H, Bast, Robert C, Bennett, John M, Benz, Edward J, Berliner, Nancy, Bertino, Joseph, Bhatia, Ravi, Bhatia, Smita, Bhojwani, Deepa, Blanke, Charles D, Bloomfield, Clara D, Bosserman, Linda, Broxmeyer, Hal E, Byrd, John C, Cabanillas, Fernando, Canellos, George Peter, Chabner, Bruce A, Chanan-Khan, Asher, Cheson, Bruce, Clarkson, Bayard, Cohn, Susan L, Colon-Otero, Gerardo, Cortes, Jorge, Coutre, Steven, Cristofanilli, Massimo, Curran, Walter J, Daley, George Q, DeAngelo, Daniel J, Deeg, H Joachim, Einhorn, Lawrence H, Erba, Harry P, Esteva, Francisco J, Estey, Elihu, Fidler, Isaiah J, Foran, James, Forman, Stephen, Freireich, Emil, Fuchs, Charles, George, James N, Gertz, Morie A, Giralt, Sergio, Golomb, Harvey, Greenberg, Peter, Gutterman, Jordan, Handin, Robert I, Hellman, Samuel, Hoff, Paulo Marcelo, Hoffman, Ronald, Hong, Waun Ki, Horowitz, Mary, Hortobagyi, Gabriel N, Hudis, Clifford, Issa, Jean Pierre, Johnson, Bruce Evan, Kantoff, Philip W, Kaushansky, Kenneth, Khayat, David, Khuri, Fadlo R, Kipps, Thomas J, Kripke, Margaret, Kyle, Robert A, Larson, Richard A, Lawrence, Theodore S, Levine, Ross, Link, Michael P, Lippman, Scott M, Lonial, Sagar, Lyman, Gary H, Markman, Maurie, Mendelsohn, John, Meropol, Neal J, Messinger, Yoav, Mulvey, Therese M, O'Brien, Susan, Perez-Soler, Roman, Pollock, Raphael, Prchal, Josef, Press, Oliver, Radich, Jerald, Rai, Kanti, Rosenberg, Saul A, Rowe, Jacob M, Rugo, Hope, Runowicz, Carolyn D, Sandmaier, Brenda M, Saven, Alan, Schafer, Andrew I, Schiffer, Charles, Sekeres, Mikkael A, Silver, Richard T, Siu, Lillian L, Steensma, David P
Published 2015

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference

by Woodward, Wendy A., Cristofanilli, Massimo, Merajver, Sofia D., Van Laere, Steven, Pusztai, Lajos, Bertucci, Francois, Berditchevski, Fedor, Polyak, Kornelia, Overmoyer, Beth, Devi, Gayathri R., Sterneck, Esta, Schneider, Robert, Debeb, Bisrat G., Wang, Xiaoping, van Golen, Kenneth L., El-Zein, Randa, Rahal, Omar M., Alexander, Angela, Reuben, James M., Krishnamurthy, Savitri, Lucci, Anthony, Ueno, Naoto T.
Published 2017

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.

by Diéras, Véronique, Rugo, Hope S, Schnell, Patrick, Gelmon, Karen, Cristofanilli, Massimo, Loi, Sherene, Colleoni, Marco, Lu, Dongrui R, Mori, Ave, Gauthier, Eric, Huang Bartlett, Cynthia, Slamon, Dennis J, Turner, Nicholas C, Finn, Richard S
Published 2019

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

by Loibl, Sibylle, Turner, Nicholas C., Ro, Jungsil, Cristofanilli, Massimo, Iwata, Hiroji, Im, Seock-Ah, Masuda, Norikazu, Loi, Sherene, Andre, Fabrice, Harbeck, Nadia, Verma, Sunil, Folkerd, Elizabeth, Theall, Kathy Puyana, Hoffman, Justin, Zhang, Ke, Bartlett, Cynthia Huang, Dowsett, Mitchell]
Published 2022

Oncological care organisation during COVID-19 outbreak.

by Onesti, Concetta Elisa, Rugo, Hope S, Generali, Daniele, Peeters, Marc, Zaman, Khalil, Wildiers, Hans, Harbeck, Nadia, Martin, Miguel, Cristofanilli, Massimo, Cortes, Javier, Tjan-Heijnen, Vivianne, Hurvitz, Sara A, Berchem, Guy, Tagliamento, Marco, Campone, Mario, Bartsch, Rupert, De Placido, Sabino, Puglisi, Fabio, Rottey, Sylvie, Müller, Volkmar, Ruhstaller, Thomas, Machiels, Jean-Pascal, Conte, PierFranco, Awada, Ahmad, Jerusalem, Guy
Published 2020

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.

by Li, Zheqi, Wu, Yang, Yates, Megan E, Tasdemir, Nilgun, Bahreini, Amir, Chen, Jian, Levine, Kevin M, Priedigkeit, Nolan M, Nasrazadani, Azadeh, Ali, Simak, Buluwela, Laki, Arnesen, Spencer, Gertz, Jason, Richer, Jennifer K, Troness, Benjamin, El-Ashry, Dorraya, Zhang, Qiang, Gerratana, Lorenzo, Zhang, Youbin, Cristofanilli, Massimo, Montanez, Maritza A, Sundd, Prithu, Wallace, Callen T, Watkins, Simon C, Fumagalli, Caterina, Guerini-Rocco, Elena, Zhu, Li, Tseng, George C, Wagle, Nikhil, Carroll, Jason S, Jank, Paul, Denkert, Carsten, Karsten, Maria M, Blohmer, Jens-Uwe, Park, Ben H, Lucas, Peter C, Atkinson, Jennifer M, Lee, Adrian V, Oesterreich, Steffi
Published 2022

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative meta...

by Cristofanilli, Massimo, DeMichele, Angela, Giorgetti, Carla, Turner, Nicholas C., Slamon, Dennis J., Im, Seock-Ah, Masuda, Norikazu, Verma, Shailendra, Loi, Sherene, Colleoni, Marco, Theall, Kathy Puyana, Huang, Xin, Liu, Yuan, Bartlett, Cynthia Huang]
Published 2022

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer:...

by Ettl, Johannes, Im, Seock-Ah, Ro, Jungsil, Masuda, Norikazu, Colleoni, Marco, Schnell, Patrick, Bananis, Eustratios, Lu, Dongrui R., Cristofanilli, Massimo, Rugo, Hope S., Finn, Richard S.]
Published 2022

Overall survival with palbociclib and fulvestrant in advanced breast cancer

by Turner, Nicholas C., Slamon, Dennis J., Ro, Jungsil, Bondarenko, Igor, Im, Seock-Ah, Masuda, Norikazu, Colleoni, Marco, DeMichele, Angela, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Loibl, Sibylle, Andre, Fabrice, Theall, K. Puyana, Huang, Xin, Giorgetti, Carla, Bartlett, C. Huang, Cristofanilli, Massimo]
Published 2022

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrin...

by Cristofanilli, Massimo, Turner, Nicholas C., Bondarenko, Igor, Ro, Jungsil, Im, Seock-Ah, Masuda, Norikazu, Colleoni, Marco, DeMichele, Angela, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Zhang, Ke, Theall, Kathy Puyana, Jiang, Yuqiu, Bartlett, Cynthia Huang, Koehler, Maria, Slamon, Dennis]
Published 2022